Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research
The Scientist
Most Recent
Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.
Tailoring ethical oversight to participant-led research
As US policymakers debate federal budget cuts, global health science hangs in the balance.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Agencies like the NSF and NIH are losing around 5 percent of their yearly budgets.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
A new project to map the activity of the human brain could receive more than $3 billion dollars in federal funds in President Obama’s upcoming budget proposal.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Engineer and materials scientist Subra Suresh will become president of Carnegie Mellon University.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
